People: Guided Therapeutics Inc (GTHP.OB)

GTHP.OB on OTC BB

0.24USD
3:58pm EST
Price Change (% chg)

-- (--)
Prev Close
$0.24
Open
$0.25
Day's High
$0.25
Day's Low
$0.23
Volume
262,740
Avg. Vol
135,799
52-wk High
$0.63
52-wk Low
$0.20

Search Stocks

Summary

Name Age Since Current Position

Michael James

55 2014 Independent Chairman and Director

Gene Cartwright

60 2014 Chief Executive Officer, Acting Chief Financial Officer, President and Director

Ronald Hart

71 2011 Independent Vice Chairman and Director

Richard Fowler

57 2009 Senior Vice President - Engineering

John Imhoff

65 2006 Independent Director

Jonathan Niloff

60 2010 Independent Director

Linda Rosenstock

63 2012 Independent Director

Biographies

Name Description

Michael James

Mr. Michael C. James is Independent Chairman and Director of Guided Therapeutics Inc. Mr. James is the Managing Partner of Kuekenhof Capital Management, LLC, a private investment management company, the Chief Financial Officer of Inergetics, Inc., a nutraceutical supplements company and also the Chief Financial Officer of Terra Tech Corporation, which is a hydroponic and agricultural company. He also holds the position of Managing Director of Kuekenhof Equity Fund, L.P. and Kuekenhof Partners, L.P. Mr. James sits on the board of directors of Inergetics, Inc. and Terra Tech Corporation. Mr. James was Chief Executive Officer of Nestor, Inc. from January 2009 to September 2009 and served on its board of directors from July 2006 to June 2009. He was employed by Moore Capital Management, Inc., a private investment management company from 1995 to 1999 and held position of Partner. He was employed by Buffalo Partners, L.P., a private investment management company from 1991 to 1994 and held the position of Chief Financial and Administrative Officer. He began his career in 1980 as a staff accountant with Eisner LLP. Mr. James received a B.S. degree in Accounting from Farleigh Dickinson University in 1980.

Gene Cartwright

Dr. Gene Cartwright, Ph.D. is Chief Executive Officer, Acting Chief Financial Officer, President and Director of Guided Therapeutics Inc. Mr. Cartwright was appointed CEO in January 2014. He brings over 30 years of experience working in the In vitro diagnostics industry. He joins Guided Therapeutics from Omnyx, LLC, a Joint Venture between GE Healthcare and the University of Pittsburgh Medical Center, where, as CEO for over four years he founded and managed the successful development of products for the field of Digital Pathology. Prior to his work with Omnyx, LLC, he was President of Molecular Diagnostics for GE Healthcare. Before joining GE, he was Divisional Vice President/General Manager for Abbott Diagnostics’ Molecular Diagnostics business. In his 24 year career at Abbott, he also served as Divisional Vice President for U.S. Marketing for five years.He received a Masters of Management degree from Northwestern’s Kellogg School of Management and also holds a Ph.D. in chemistry from Stanford University and an AB from Dartmouth College.

Ronald Hart

Dr. Ronald W. Hart, Ph.D., is Independent Vice Chairman and Director of Guided Therapeutics Inc. He has served as a member of the board since March 2007 and was elected Vice Chairman in 2011. He has published 600 peer-reviewed publications, has been appointed to a number of academic positions and is credited with developing the first direct proof that DNA is causal in certain forms of cancer. He chaired a number of federal committees and task forces, including the development and implementation of the Technology Transfer Act of 1986 and the White House Task Force on Chemical Carcinogenesis. In 1980, Dr. Hart was appointed Director of the National Center for Toxicological Research, the research arm of the FDA, a position he held until 1992. In 1992, Dr. Hart was the first ever Presidential Appointee to the position of Distinguished Scientist in Residence for the US Public Health Service/FDA, a position he held until his retirement in 2000. Dr. Hart received his Ph.D. in physiology and biophysics from the University of Illinois.

Richard Fowler

Mr. Richard L. Fowler is Senior Vice President - Engineering of Guided Therapeutics Inc. Mr. Fowler is an accomplished Executive with experience in the management of businesses that sell, market, produce and develop sophisticated medical devices and instrumentation. Mr. Fowler’s 25 plus years of experience includes assembling and managing teams, businesses and negotiating contracts, conducting litigation, and developing ISO, CE, FDA QSR, GMP and GCP compliant processes and products. He is adept at providing product life cycle management through effective process definition and communication - from requirements gathering, R&D feasibility, product development, product launch, production startup and support. Mr. Fowler combines analytical, out-of-the-box, and strategic thinking with leadership, technical, and communication skills and he excels in dynamic, demanding environments while remaining pragmatic and focused. He is able to deliver high risk projects on time and under budget as well as enhance operational effectiveness through cross-functional team leadership (R&D, marketing, product development, operations, QA, sales, service, and finance). In addition, Mr. Fowler is well versed in global medical device regulatory and product compliance requirements.

John Imhoff

Dr. John E. Imhoff, M.D., is an Independent Director of Guided Therapeutics Inc., since April 2006. Dr. Imhoff is an ophthalmic surgeon who specializes in cataract and refractive surgery. He is one of the principal stockholders and invests in many other private and public companies. He has a B.S. in Industrial Engineering from Oklahoma State University, an M.D. from the University of Oklahoma and completed his ophthalmic residency at the Dean A. McGee Eye Institute. He has worked as an ophthalmic surgeon and owner of Southeast Eye Center since 1983.

Jonathan Niloff

Dr. Jonathan M. Niloff, M.D., is an Independent Director of Guided Therapeutics Inc., since April 2010. Dr. Niloff is the Founder, Chairman and Chief Medical Officer of MedVentive Inc. Prior to joining MedVentive, Dr. Niloff served as President of the Beth Israel Deaconess Physicians Organization, Medical Director for Obstetrics and Gynecology for its Affiliated Physicians Group, and Chief of Gynecology at New England Deaconess Hospital. He served as an Associate Professor of Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School. Dr. Niloff received his undergraduate education at The Johns Hopkins University, an MD degree from McGill University, and an MBA degree from Boston University.

Linda Rosenstock

Dr. Linda M. Rosenstock, M.D., is Independent Director of Guided Therapeutics Inc., since April 16, 2012. Dr. Linda Rosenstock is Dean of the University of California, Los Angeles (UCLA) Fielding School of Public Health, a position she has held since 2000. She holds appointments as Professor of Medicine and Environmental Health Sciences and is a recognized authority in broad areas of public health and science policy. Internationally, Dr. Rosenstock has been active in teaching and research in many developing countries and has served as an advisor to the World Health Organization. Dr. Rosenstock also chaired the United Auto Workers/General Motors Occupational Health Advisory Board. She is an Honorary Fellow of the Royal College of Physicians and an elected member of the National Academy of Sciences' Institute of Medicine where she has served as a member of their Board on Health Sciences Policy and Chair of the Committee for Preventive Services for Women. In January 2011, she was appointed by President Obama to the Advisory Group on Prevention, Health Promotion and Integrative and Public Health. Before coming to UCLA in 2000, Dr. Rosenstock served as Director of the National Institute for Occupational Safety and Health (NIOSH) for seven years. During her tenure, she was instrumental in creating the National Occupational Research Agenda, a framework for guiding occupational safety and health research, and in expanding the agency's responsibilities. In recognition of her efforts, Dr. Rosenstock received the Presidential Distinguished Executive Rank Award, the highest executive service award in the government and was the James P. Keogh Award Winner for 2011 in appreciation of a lifetime of extraordinary leadership in occupational health and safety. Dr. Rosenstock received her M.D. and M.P.H. from The Johns Hopkins University. She conducted her advanced training at the University of Washington, where she was Chief Resident in Primary Care Internal Medicine and a Robert Wood Johnson Clinical Scholar.

Basic Compensation

Name Fiscal Year Total

Michael James

--

Gene Cartwright

--

Ronald Hart

--

Richard Fowler

197,000

John Imhoff

--

Jonathan Niloff

--

Linda Rosenstock

--
As Of 30 Dec 2013

Options Compensation

Search Stocks